169 related articles for article (PubMed ID: 9155047)
21. Tretinoin or retinol enhancement of lymphokine-activated killer cell proliferation and cytotoxicity against human bladder cancer cells in vitro.
Wang ZP; Zheng RL; Chen YR; Liu GD
Zhongguo Yao Li Xue Bao; 1997 Nov; 18(6):522-4. PubMed ID: 10322910
[TBL] [Abstract][Full Text] [Related]
22. Interferon gamma but not tumor necrosis factor alpha decreases susceptibility of human renal cell cancer cell lines to lymphokine-activated killer cells.
Tomita Y; Watanabe H; Kobayashi H; Nishiyama T; Tsuji S; Fujiwara M; Sato S
Cancer Immunol Immunother; 1992; 35(6):381-7. PubMed ID: 1356627
[TBL] [Abstract][Full Text] [Related]
23. Ubenimex treatment enhances the susceptibility of gastric cancer cell lines to lymphokine-activated killer cells.
Iwahashi M; Tanimura H; Yamaue H; Tani M; Noguchi K; Mizobata S; Tsunoda T; Tamai M; Hotta T; Arii K
Anticancer Res; 1994; 14(4A):1563-8. PubMed ID: 7979186
[TBL] [Abstract][Full Text] [Related]
24. All trans retinoic acid enhances human LAK activity.
Fegan C; Bailey-Wood R; Coleman S; Phillips SA; Neale L; Hoy T; Whittaker JA
Eur J Haematol; 1995 Feb; 54(2):95-100. PubMed ID: 7698301
[TBL] [Abstract][Full Text] [Related]
25. Altered expression of P-glycoprotein and cellular adhesion molecules on human multi-drug-resistant tumor cells does not affect their susceptibility to NK- and LAK-mediated cytotoxicity.
Scheper RJ; Dalton WS; Grogan TM; Schlosser A; Bellamy WT; Taylor CW; Scuderi P; Spier C
Int J Cancer; 1991 Jun; 48(4):562-7. PubMed ID: 1710609
[TBL] [Abstract][Full Text] [Related]
26. A novel retinoic acid analog, 4-amino-2-trifluoromethyl-phenyl retinate, inhibits gastric cancer cell growth.
Hu KW; Pan XH; Chen FH; Qin R; Wu LM; Zhu HG; Wu FR; Ge JF; Han WX; Yin CL; Li HJ
Int J Mol Med; 2014 Feb; 33(2):415-22. PubMed ID: 24317440
[TBL] [Abstract][Full Text] [Related]
27. Recombinant gamma interferon provokes resistance of human breast cancer cells to spontaneous and IL-2 activated non-MHC restricted cytotoxicity.
Jabrane-Ferrat N; Calvo F; Faille A; Lagabrielle JF; Boisson N; Quillet A; Fradelizi D
Br J Cancer; 1990 Apr; 61(4):558-62. PubMed ID: 2109997
[TBL] [Abstract][Full Text] [Related]
28. Growth inhibition of gastric cancer cells by all-trans retinoic acid through arresting cell cycle progression.
Wu Q; Chen Z; Su W
Chin Med J (Engl); 2001 Sep; 114(9):958-61. PubMed ID: 11780391
[TBL] [Abstract][Full Text] [Related]
29. Cytocidal activity of PBL, LAK, and IDEC-C2B8 and expression of HLA class 1, ICAM-1, and CD20 in vincristine-resistant hematologic cell lines.
Hirose M; Hamano S; Tobinai K; Kuroda Y
J Immunother; 1999 May; 22(3):237-44. PubMed ID: 10335483
[TBL] [Abstract][Full Text] [Related]
30. Characterization of two novel retinoic acid-resistant cell lines derived from HL-60 cells following long-term culture with all-trans-retinoic acid.
Mori J; Suzuki S; Hara M; Kaneko A; Yamashita K; Kumagai M; Sakuma T; Kakizawa T; Yamazaki M; Takeda T; Miyamoto T; Ichikawa K; Hashizume K
Jpn J Cancer Res; 1999 Jun; 90(6):660-8. PubMed ID: 10429659
[TBL] [Abstract][Full Text] [Related]
31. Retinoic acid regulates cell cycle progression and cell differentiation in human monocytic THP-1 cells.
Chen Q; Ross AC
Exp Cell Res; 2004 Jul; 297(1):68-81. PubMed ID: 15194426
[TBL] [Abstract][Full Text] [Related]
32. Culture medium induced morphological changes of melanoma cells associated with change in sensitivity to lysis by lymphokine-activated killer cells.
Perng YP; Lin CC; Perng IM; Shen YC; Chuang CK; Liao SK
Cancer Biother Radiopharm; 1997 Oct; 12(5):317-31. PubMed ID: 10851482
[TBL] [Abstract][Full Text] [Related]
33. Susceptibility of human leukemia to allogeneic and autologous lymphokine-activated killer cell activity: analysis of 252 samples.
Teichmann JV; Ludwig WD; Thiel E
Nat Immun; 1992; 11(3):117-32. PubMed ID: 1392400
[TBL] [Abstract][Full Text] [Related]
34. Cell cycle assessment of adoptive transferred lymphokine activated killer cells.
Watanabe R; Tanaka N; Naomoto Y; Moreira LF; Orita K
Jpn J Clin Oncol; 1994 Apr; 24(2):59-65. PubMed ID: 8158860
[TBL] [Abstract][Full Text] [Related]
35. The lack of NK cytotoxicity associated with fresh HUCB may be due to the presence of soluble HLA in the serum.
Webb BJ; Bochan MR; Montel A; Padilla LM; Brahmi Z
Cell Immunol; 1994 Dec; 159(2):246-61. PubMed ID: 7994757
[TBL] [Abstract][Full Text] [Related]
36. [Regulation of cell cycle by retinoic acid in gastric cancer cells].
Chen ZM; Wu Q; Chen YQ; Su WJ
Shi Yan Sheng Wu Xue Bao; 1999 Jun; 32(2):135-40. PubMed ID: 12548778
[TBL] [Abstract][Full Text] [Related]
37. Retaliation against tumor cells showing aberrant HLA expression using lymphokine activated killer-derived T cells.
Falk CS; Noessner E; Weiss EH; Schendel DJ
Cancer Res; 2002 Jan; 62(2):480-7. PubMed ID: 11809699
[TBL] [Abstract][Full Text] [Related]
38. Interleukin 2 protects hairy leukemic cells from lymphokine-activated killer cell-mediated cytotoxicity.
Reiter Z; Taylor MW
Cancer Res; 1993 Aug; 53(15):3555-60. PubMed ID: 7687924
[TBL] [Abstract][Full Text] [Related]
39. Role of adhesion molecules in lymphokine-activated killer cell killing of bladder cancer cells: further evidence for a third ligand for leucocyte function-associated antigen-1.
Jackson AM; Alexandrov AB; Prescott S; James K; Chisholm GD
Immunology; 1992 Jun; 76(2):286-91. PubMed ID: 1353063
[TBL] [Abstract][Full Text] [Related]
40. Human tumor cell line resistance to chemotherapeutic agents does not predict resistance to natural killer or lymphokine-activated killer cell-mediated cytolysis.
Harker WG; Tom C; McGregor JR; Slade L; Samlowski WE
Cancer Res; 1990 Sep; 50(18):5931-6. PubMed ID: 1975512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]